[go: up one dir, main page]

WO2018154145A3 - Retinol replacement in skin treatment - Google Patents

Retinol replacement in skin treatment Download PDF

Info

Publication number
WO2018154145A3
WO2018154145A3 PCT/EP2018/058113 EP2018058113W WO2018154145A3 WO 2018154145 A3 WO2018154145 A3 WO 2018154145A3 EP 2018058113 W EP2018058113 W EP 2018058113W WO 2018154145 A3 WO2018154145 A3 WO 2018154145A3
Authority
WO
WIPO (PCT)
Prior art keywords
relates
present
retinol
replacement
skin treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2018/058113
Other languages
French (fr)
Other versions
WO2018154145A2 (en
Inventor
Dominik Stuhlmann
Ann-Christin WESELOH
Nicole Titze
Sabine Lange
Sebastian BRUNCKE
Join BENOIT
Gabriele Vielhaber
Marielle Le Maire
Karima BENAISSI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise AG filed Critical Symrise AG
Priority to PCT/EP2018/058113 priority Critical patent/WO2018154145A2/en
Publication of WO2018154145A2 publication Critical patent/WO2018154145A2/en
Publication of WO2018154145A3 publication Critical patent/WO2018154145A3/en
Priority to PCT/EP2019/058097 priority patent/WO2019185923A1/en
Priority to BR112020019928-1A priority patent/BR112020019928A2/en
Priority to CN201980023365.7A priority patent/CN111918637A/en
Priority to EP19714432.2A priority patent/EP3773445B1/en
Priority to CA3094418A priority patent/CA3094418A1/en
Priority to US17/042,263 priority patent/US11801210B2/en
Priority to EP24190385.5A priority patent/EP4442241A3/en
Priority to KR1020207031230A priority patent/KR20200138343A/en
Priority to ES19714432T priority patent/ES2991289T3/en
Priority to CN202311173282.0A priority patent/CN117481998A/en
Priority to JP2020552782A priority patent/JP2021519774A/en
Anticipated expiration legal-status Critical
Priority to JP2024044544A priority patent/JP2024091639A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to novel cosmetic and therapeutic uses of one or more compounds of the general formula (1) as described herein, preferably hydroxyanasatil retinoate and/or retinoic acid, 3,3-dimethyl-2-oxobutyl ester. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, comprising or consisting of compound(s) of formula (1) and one or more cosmetically and/or pharmaceutically acceptable carriers. The present invention also relates to novel uses of such compositions according to the invention.
PCT/EP2018/058113 2018-03-29 2018-03-29 Compounds for skin improvement / treatment Ceased WO2018154145A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
PCT/EP2018/058113 WO2018154145A2 (en) 2018-03-29 2018-03-29 Compounds for skin improvement / treatment
CN202311173282.0A CN117481998A (en) 2018-03-29 2019-03-29 Retinol Alternatives in Skin Treatments
JP2020552782A JP2021519774A (en) 2018-03-29 2019-03-29 Replacement of retinol in skin treatment
CA3094418A CA3094418A1 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment
KR1020207031230A KR20200138343A (en) 2018-03-29 2019-03-29 Compound for skin improvement/treatment
CN201980023365.7A CN111918637A (en) 2018-03-29 2019-03-29 Retinol substitute in skin treatment
EP19714432.2A EP3773445B1 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment
PCT/EP2019/058097 WO2019185923A1 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment
US17/042,263 US11801210B2 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment
EP24190385.5A EP4442241A3 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment
BR112020019928-1A BR112020019928A2 (en) 2018-03-29 2019-03-29 REPLACEMENT OF RETINOL IN SKIN TREATMENT
ES19714432T ES2991289T3 (en) 2018-03-29 2019-03-29 Replacing retinol for skin care
JP2024044544A JP2024091639A (en) 2018-03-29 2024-03-21 Alternatives to Retinol in Skin Treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/058113 WO2018154145A2 (en) 2018-03-29 2018-03-29 Compounds for skin improvement / treatment

Publications (2)

Publication Number Publication Date
WO2018154145A2 WO2018154145A2 (en) 2018-08-30
WO2018154145A3 true WO2018154145A3 (en) 2018-11-01

Family

ID=62091826

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2018/058113 Ceased WO2018154145A2 (en) 2018-03-29 2018-03-29 Compounds for skin improvement / treatment
PCT/EP2019/058097 Ceased WO2019185923A1 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/058097 Ceased WO2019185923A1 (en) 2018-03-29 2019-03-29 Retinol replacement in skin treatment

Country Status (9)

Country Link
US (1) US11801210B2 (en)
EP (2) EP4442241A3 (en)
JP (2) JP2021519774A (en)
KR (1) KR20200138343A (en)
CN (2) CN111918637A (en)
BR (1) BR112020019928A2 (en)
CA (1) CA3094418A1 (en)
ES (1) ES2991289T3 (en)
WO (2) WO2018154145A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11931331B2 (en) 2018-07-27 2024-03-19 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
CN111826383B (en) * 2020-07-16 2022-08-02 昆明理工大学 Application of Danbo black soybean superoxide dismutase gene in improving plant aluminum tolerance
WO2022122137A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising antimicrobials and (bio)-alkanediols for skin protection
WO2022122136A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with antioxidants
WO2022122131A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising lipophilic compounds and one or more (bio)-alkanediols
WO2022122135A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising (bio)-alkanediols with antimicrobials for product protection
WO2022122140A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with active ingredients
WO2022122132A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising natural polymers and one or more (bio)-alkanediols
CN113521004B (en) * 2021-06-24 2022-02-22 中国农业科学院农产品加工研究所 Preparation method of high-load cannabidiol oil-in-water macromolecular particle emulsion
CN113876610B (en) * 2021-11-15 2023-09-26 华熙生物科技股份有限公司 Composition capable of enhancing cell energy and improving skin resistance as well as preparation method and application thereof
CN114652636B (en) * 2022-03-10 2023-11-17 广东丸美生物技术股份有限公司 Anti-wrinkle repair composition, preparation method thereof and cosmetic containing composition
CN114617816B (en) * 2022-04-13 2023-10-03 新柏妆(广州)科技研发中心有限公司 Anti-aging composition and preparation method thereof
US12201717B2 (en) * 2022-10-31 2025-01-21 Skinfix Inc. Compositions and methods for supporting skin barrier homeostasis
KR102852222B1 (en) * 2022-11-23 2025-08-29 박용두 Pharmaceutical composition for preventing or treating pigmented skin disease comprising salsalate
FR3142344A1 (en) * 2022-11-30 2024-05-31 L'oreal Retinol-based composition
WO2024199669A1 (en) 2023-03-31 2024-10-03 Symrise Ag Preparations comprising hydroxy pinacolone retinoate
CN116211775A (en) * 2023-04-17 2023-06-06 卓丝元生(深圳)研发有限公司 anti aging skin care products

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009788A1 (en) * 1987-06-12 1988-12-15 Molecular Design International, Inc. Topical prodrugs for treatment of acne and skin diseases
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
WO1990006751A1 (en) * 1988-12-14 1990-06-28 Molecular Design International, Inc. Dermal uses of non-irritating retinoids
US20070166267A1 (en) * 2006-01-18 2007-07-19 Grant Industries, Inc. Anti-wrinkle composition
WO2008070116A2 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
WO2012051614A2 (en) * 2010-10-15 2012-04-19 Kulesza John E Delivery of hydrophobic bioactive agents

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3740186A1 (en) 1987-06-24 1989-01-05 Beiersdorf Ag DESODORATING AND ANTIMICROBIAL COMPOSITION FOR USE IN COSMETIC OR TOPICAL PREPARATIONS
DE3938140A1 (en) 1989-11-16 1991-08-08 Beiersdorf Ag DESODRATING COSMETIC AGENTS
DE4009347A1 (en) 1990-03-23 1991-09-26 Beiersdorf Ag DESODRATING COSMETIC AGENTS
GB9110651D0 (en) 1991-05-15 1991-07-03 Stiefel Laboratories Composition and method of enhancing sun tanning
DE4204321A1 (en) 1992-02-13 1993-08-19 Beiersdorf Ag METHOD FOR THE INSULATION AND CLEANING OF FATS AND HYDROXYFASTAEURES AND USES OF HYDROXYFAST ATTACHMENTS AND PREPARATIONS THEREOF CONTAINED
DE4229737C2 (en) 1992-09-05 1996-04-25 Beiersdorf Ag Deodorizing cosmetic products containing fatty acids
DE4229707A1 (en) 1992-09-05 1994-03-10 Beiersdorf Ag Germicide drug combinations
DE4237081C2 (en) 1992-11-03 1996-05-09 Beiersdorf Ag Use of di- or triglycerol esters as Deowirkstoffe
DE4309372C2 (en) 1993-03-23 1997-08-21 Beiersdorf Ag Cosmetic deodorants containing mixtures of wool wax acids or wool wax acid components and fatty acid partial glycerides of unbranched fatty acids
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
DE4324219C2 (en) 1993-07-20 1995-08-10 Beiersdorf Ag Deodorant active ingredient combinations based on alpha, omega-alkane dicarboxylic acids and wool wax acids
US20030147937A1 (en) 2000-04-12 2003-08-07 Thomas Schwarz Use of compatible solutes as substances having free radical scavenging properties
ATE446083T1 (en) 2000-08-18 2009-11-15 Bitop Gmbh USE OF DI-SUGAR ALCOHOL PHOSPHATES TO PROTECT HUMAN SKIN CELLS FROM UV AND/OR IR RADIATION
DE10055940A1 (en) 2000-11-10 2002-05-29 Bayer Ag New indanylid compounds
DE10254872A1 (en) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilic acid amides and their derivatives as cosmetic and pharmaceutical active ingredients
DE10341654A1 (en) 2003-09-08 2005-04-07 Beiersdorf Ag Agent for use on the skin and / or the hair containing 4-substituted cyclohexene compounds
DE102004020714A1 (en) 2004-04-26 2005-11-10 Beiersdorf Ag Skin and / or hair means containing compounds with isoprenoid structure
DE102004029239A1 (en) 2004-05-03 2005-12-01 Symrise Gmbh & Co. Kg Benylidene-β-dicarbonyl compounds as new UV absorbers
JP4927718B2 (en) 2004-06-18 2012-05-09 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト Blackberry extract
DE102004036092A1 (en) 2004-07-24 2006-02-16 Beiersdorf Ag Skin and / or hair products containing compounds to increase the tanning of the skin
DE102004038485A1 (en) 2004-08-07 2006-02-23 Symrise Gmbh & Co. Kg alpha-benzoyl-cinnamonitriles as new UV absorbers
EP1807039A1 (en) 2004-10-25 2007-07-18 Symrise GmbH & Co. KG Use of glycosylated flavanones for the browning of skin or hair
BRPI0517684A (en) * 2004-11-09 2008-10-14 Imaginative Res Associates Inc retinoid solutions and formulations made from the same
ES2321218T3 (en) 2004-11-22 2009-06-03 SYMRISE GMBH & CO. KG FORMULATIONS THAT INCLUDE CERAMIDS AND / OR PSEUDOCERAMIDS AND (ALFA-) BISABOLOL TO COMBAT SKIN DAMAGE.
EP1937366B1 (en) 2005-10-14 2011-12-14 Symrise AG Synergistic mixtures of bisabolol and ginger extract
WO2007110415A2 (en) 2006-03-27 2007-10-04 Symrise Gmbh & Co. Kg Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
DE102006043587A1 (en) 2006-09-16 2008-03-27 Symrise Gmbh & Co. Kg 2-methyl-2-alkenyl-substituted 1,3-dioxanes as fragrances
EP1915982A1 (en) 2006-10-20 2008-04-30 Symrise GmbH & Co. KG Use of 1,2-decanediol for reducing sebum concentration and/or for enhancing penetration of actives into skin areas, and cosmetic and/or dermatological compositions comprising 1,2-decanediol
DE102006050398A1 (en) 2006-10-20 2008-04-24 Henkel Kgaa Cosmetic agent containing purine and / or purine derivative and taurine
EP1923041A1 (en) 2006-10-20 2008-05-21 Symrise GmbH & Co. KG Use of C10-C14 alkane diols for the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff, and compositions comprising C10-C14 alkane diols
US20130310355A1 (en) 2009-12-15 2013-11-21 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system
WO2014116653A1 (en) 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof
WO2015187921A1 (en) * 2014-06-04 2015-12-10 Arbonne International, Llc Clear compositions and methods for the delivery of active ingredients for skin care
CA2974196C (en) 2015-01-20 2023-12-12 TetraDerm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009788A1 (en) * 1987-06-12 1988-12-15 Molecular Design International, Inc. Topical prodrugs for treatment of acne and skin diseases
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
WO1990006751A1 (en) * 1988-12-14 1990-06-28 Molecular Design International, Inc. Dermal uses of non-irritating retinoids
US20070166267A1 (en) * 2006-01-18 2007-07-19 Grant Industries, Inc. Anti-wrinkle composition
WO2008070116A2 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
WO2012051614A2 (en) * 2010-10-15 2012-04-19 Kulesza John E Delivery of hydrophobic bioactive agents

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931331B2 (en) 2018-07-27 2024-03-19 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Also Published As

Publication number Publication date
EP4442241A2 (en) 2024-10-09
US11801210B2 (en) 2023-10-31
JP2021519774A (en) 2021-08-12
ES2991289T3 (en) 2024-12-03
JP2024091639A (en) 2024-07-05
KR20200138343A (en) 2020-12-09
EP3773445A1 (en) 2021-02-17
US20210045983A1 (en) 2021-02-18
CN117481998A (en) 2024-02-02
EP4442241A3 (en) 2024-12-25
EP3773445B1 (en) 2024-07-24
CA3094418A1 (en) 2019-10-03
BR112020019928A2 (en) 2021-01-05
WO2018154145A2 (en) 2018-08-30
WO2019185923A1 (en) 2019-10-03
CN111918637A (en) 2020-11-10

Similar Documents

Publication Publication Date Title
WO2018154145A3 (en) Retinol replacement in skin treatment
WO2010097480A3 (en) Menthyl carbamate compounds as skin and/or hair lightening actives
PH12020550341A1 (en) Niraparib formulations
KR20150057921A (en) Composition for skin cell anti-inflammation or skin whitening
WO2012143576A3 (en) Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
WO2010122178A3 (en) Cyclohexyl carbamate compounds as skin and/or hair lightening actives
CA2532596A1 (en) Anti-inflammatory formulations
MX354985B (en) A toy building set.
HK1202448A1 (en) Topical formulation for administering a compound
MY204380A (en) Nonracemic mixtures and uses thereof
WO2021129617A3 (en) Topical composition for preventing, alleviating, or treating skin allergies, and use therefor
EP4552650A3 (en) Methods and compositions for treatment of skin
MX2023000870A (en) Diester cosmetic formulations and uses thereof.
SA519410993B1 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
AU2108500A (en) Galenic formulation containing biotin
NZ609655A (en) Pharmaceutical topical composition of mupirocin
EP4599892A3 (en) Boronic acid derivatives and therapeutic uses thereof
JP2006070025A (en) Antiseptic / antifungal composition
WO2004106307A3 (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
PH12021551396A1 (en) Active ester derivatives of testosterone, compositions and uses thereof
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids
WO2012143857A8 (en) Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin
PT1809383E (en) Cosmetic compositions
WO2012098342A8 (en) (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
WO2010070152A3 (en) Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18721280

Country of ref document: EP

Kind code of ref document: A2